Public Foundation for Microbial Chemistry Research
Basic information
- Head office
- 1-1-1 Nihonbashi Motomachi, Chuo-ku, Tokyo
- Chief executive
- No information
- Capital
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 1958-12-10
- End date
Websites
Business
Related companies
—
Network
History
Dr. Hanzō Umezawa (then Director of the Antibiotics Division at the National Institute of Infectious Diseases and Professor at the University of Tokyo Applied Microbiology Institute) and colleagues discovered a new antibiotic, kanamycin. Kanamycin proved highly effective in treating severe infections caused by resistant bacteria at the time.![]()
Kanamycin was released in our country as a chemotherapeutic agent for infectious diseases. It was also launched in the United States, and began to be widely used in Europe and other countries. With approval from the Minister of Health, the Public Foundation for Microbial Chemistry Research Association (Chairman Shinji Yoshino, Director-General Hanzō Umezawa) was established. At the behest of then Health Minister Ryōgo Hashimoto, the patent revenues from kanamycin were allocated to the foundation's fund.![]()
The Microbial Chemistry Research Institute was established in Kamiozaki, Shinagawa-ku, Tokyo, with Dr. Hanzō Umezawa as director, initiating research activities.![]()
Kasugamycin, effective against rice blast disease, was discovered. Kasugamycin was confirmed to be a low-toxicity, safe pesticide.![]()
To expand research, a new building was added to the Microbial Chemistry Research Institute. It was confirmed that bleomycin showed clinical therapeutic effects against squamous cell carcinoma.![]()
To investigate the distribution of resistant bacteria and plasmids (chromosomal genes) involved in resistance, a branch Epizome Research Institute was established in Fujimi Village, Seta District, Gunma Prefecture.![]()
The 6th International Chemotherapy Conference was held. The antibacterial antibiotic bekamycin was released. The anticancer antibiotic bleomycin was released.![]()
Kasugamycin was released as a specific cure for rice blast disease. The antibacterial antibiotic josamycin was released.![]()
Dr. Atsuji Ichikawa was elected as president of the association. The derivative of kanamycin (jibekasin) that is broadly effective against resistant bacteria including Pseudomonas aeruginosa was synthesized.![]()
To enhance organic synthesis research, the Biological Organic Chemistry Research Institute was established in Ida, Nakahara-ku, Kawasaki City, Kanagawa Prefecture, with Dr. Jun'ō Umezawa as director, initiating research activities.![]()
Held the 15th anniversary symposium of the Microbiological Chemistry Research Institute. Proceedings: Jap. J. Antibiot, 30, supplement (1977).![]()
Held the 5th anniversary symposium of the Biological Organic Chemistry Research Institute. Proceedings: Jap. J. Antibiot, 32, supplement (1979).![]()
The foundation's significant contribution to academic promotion was recognized, and by partially changing donation practices, it became a foundation approved by the Ministers of Health and Education. Held the symposium "Trends in Antibiotic Research". Proceedings: "Trends in Antibiotic Research", edited by H. Umezawa et al., 1982, Japan Antibiotic Research Association. The anti‑cancer antibiotic aclarvacin was released.![]()
For research on chemotherapy and immunotherapy, the Chemotherapy Research Institute, equipped with an animal experiment facility and radiation experiment equipment, was established in Miyamoto, Numazu City, Shizuoka Prefecture.![]()
Founder Dr. Hamou Umezawa passed away at the age of 72. Throughout his life, Dr. Umezawa discovered numerous useful antibiotics such as kanamycin, bleomycin, and kasugamycin, contributing to the development of human health and welfare, and, utilizing broad knowledge in medicine, biology, pharmacy, and organic chemistry, led the global academic community and pioneered various new research fields.![]()
Dr. Tomio Takeuchi (executive director) was elected as the chairman of the association. Held the 25th anniversary symposium of the Microbiological Chemistry Research Institute. Proceedings: "Horizons on Antibiotic Research", edited by B. D. Davis et al., 1988, Japan Antibiotic Research Association. The anti‑cancer antibiotic ubimex (bestatin) was released.![]()
To preserve and exhibit items that tell the achievements of the late Dr. Hamou Umezawa and to promote that knowledge, the Umezawa Hamou Memorial Hall was established in Tamagawa, Setagaya‑ku, Tokyo. The anti‑cancer antibiotic pilarbicin was released.![]()
To improve the research environment, the Microbiological Chemistry Research Institute Annex, which expanded the conference rooms and library, was established adjacent to the new building. The immunosuppressant gusperimus (deoxysparagin) was released.![]()
Dr. Tomio Yamakawa (photo) was elected as the president of the association, and Dr. Yoshio Nonomura was elected as the chairman.![]()
In order to streamline the organization of the association, the institute's structure was reformed and names changed. The Microbiological Chemistry Research Institute was renamed the Microbiological Chemistry Research Center, the Biological Organic Chemistry Research Institute became the Hiyoshi Pharmaceutical Chemistry Research Institute, and the Chemotherapy Research Institute became the Numazu Pharmaceutical Medical Science Research Institute. The Epizome Research Institute was closed. Dr. Daisuke Akamatsu was elected as director of the Microbiological Chemistry Research Center.![]()
Renamed the Microbiological Chemistry Research Center to the Microbiological Chemistry Research Institute. The Hiyoshi Pharmaceutical Chemistry Research Institute was renamed the Microbiological Chemistry Research Institute Hiyoshi Branch, and the Numazu Pharmaceutical Medical Science Research Institute was renamed the Microbiological Chemistry Research Institute Numazu Branch. Dr. Akio Nomoto was elected as chairman and director (biological division) of the Microbiological Chemistry Research Institute. Dr. Masakatsu Shibasaki was elected as executive director and director (chemical division) of the Microbiological Chemistry Research Institute. The fifth president, Dr. Tomio Yamakawa, spoke "Microbiological Chemistry Research Association and Me" and a new organizational restructuring was carried out.![]()
It became a public interest foundation, the Microbiological Chemistry Research Association. The Virus Research Division was abolished, and the Basic Biology Research Division was newly established.![]()
Established a Resource Management Office in the Intellectual Property Information Department. Established a Research Cooperation Office in the Intellectual Property Information Department.![]()
The new research building was completed in May. Consequently, the Hiyoshi branch was closed and the organization was restructured.![]()
Reorganized the Molecular Structure Analysis Division into the Structural Biology Research Division and the Molecular Structure Analysis Office. Restructured the Intellectual Property Information Department into the Intellectual Property Information Office. Integrated the Resource Management Office into the Second Biological Activity Division, and merged the Research Cooperation Office into the Secretariat. The Systems Management Department was also merged into the Secretariat. To honor the achievements of the foundation's founder, Dr. Hamuji Umezawa, and to introduce the current Microbial Chemistry Research Association, the Umezawa Hamuji Memorial Museum in Meguro (HUM) was established.![]()
Our institute was ranked first among Japanese research institutions for publishing the highest proportion of high‑quality scientific papers in the natural sciences between 2012 and 2017, according to the Nature Index 2018 Japan.![]()
Reorganized the Molecular Structure Analysis Office into the Molecular Structure Analysis Division and the Intellectual Property Information Office into the Intellectual Property Information Division.![]()
Dr. Takao Shimizu was elected director. Established an Information Management Office in the Intellectual Property Information Department.![]()
News
There is no news.
Public records
National Tax Agency basic information3010705001652
- Trade name
- 公益財団法人微生物化学研究会
- Trade name (kana)
- ビセイブツカガクケンキュウカイ
- Name in English
- Corporation type
- 399
- Address
- 〒141-0021 東京都品川区上大崎3丁目14番23号
- Postal code
- 1410021
- Prefecture code
- 13
- City code
- 109
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2018-07-10
- Change date
- 2015-10-05
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 01
- Correction type
- 1
- Trade name image ID
- Address image ID
- Sequence number
- 1626253
METI gBizINFO3010705001652
- Corporate number
- 3010705001652
- Trade name
- 公益財団法人微生物化学研究会
- Trade name (kana)
- ビセイブツカガクケンキュウカイ
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都品川区上大崎3丁目14番23号
- Postal code
- 1410021
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 品川区
- City code
- 109
- Street address
- 上大崎3丁目14番23号
- Organisation type
- 399
- Processing type
- 01
- Correction type
- 1
- Status
- Representative
- Capital
- Employees
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2018-07-10
- Key information
- 3010705001652